Breaking News Instant updates and real-time market news.

IQV

Iqvia

$99.13

-2.99 (-2.93%)

05:56
05/17/18
05/17
05:56
05/17/18
05:56

Iqvia data issues 'likely just a hiccup,' says Mizuho

Mizuho analyst Ann Hynes believes the data issues brought up yesterday by the FDA are "likely just a hiccup" for Iqvia. The analyst feels comfortable that the issue does not have ramifications on a significant portion of Iqvia's business, and that the issue has been resolved. She reiterates a Neutral rating on the shares with a $97 price target.

  • 16

    May

IQV Iqvia
$99.13

-2.99 (-2.93%)

04/13/18
GSCO
04/13/18
UPGRADE
GSCO
Buy
Iqvia upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Robert Jones upgraded Iqvia Holdings to Buy with a slightly reduced price target of $114. The analyst views consensus expectations as conservative and the company's Next-Gen clinical offering as differentiated. He wants to add more Contract Research Organization exposure heading into the Q1 earnings reports "despite Biopharma M&A jitters."
05/16/18
EVER
05/16/18
NO CHANGE
Target $113
EVER
Outperform
FDA report on Iqvia data quality a 'non-issue,' says Evercore ISI
After the FDA reported certain issues with Iqvia's sales data regarding opioid drug products, Evercore ISI analyst Ross Muken called the news a "non-issue," stating that it has nothing to do with the company's clinical trial business and is "purely a minor error in the sales data." He believes the stocks' pullback on the news is an overreaction and would be a buyer of any continued weakness. Muken has an Outperform rating and $113 price target on Iqvia shares, which are down about 4% to $97.66 in early afternoon trading.
05/16/18
BARD
05/16/18
NO CHANGE
Target $109
BARD
Neutral
Iqvia quality issues 'more than just a small overhang,' says Baird
Baird analyst Eric Coldwell says that while his initial thought upon hearing of the data quality issues was buy the weakness in Iqvia shares, he now feels the news represents "more than just a small overhang." The FDA data quality issue is a "new risk and all the potential ramifications will take some time to digest," Coldwell tells investors in an intraday research note. Iqvia is well off the day's lows but remains down 4.6% to $97.43 in afternoon trading. Coldwell has a Neutral rating on the shares with a $109 price target. He points out that FDA Commissioner Gottlieb is calling for Iqvia to immediately retain an auditor to review the controlled substance data and separately retain a third party to do an independent audit of data and process quality for all of its products used by the agency.
05/16/18
STFL
05/16/18
NO CHANGE
Target $128
STFL
Buy
Cost, scope of FDA requested audit key questions for Iqvia, says Stifel
After the FDA reported its scientists found inaccurate data items provided to the agency by an Iqvia database and requested the company hire an independent third party auditor to review the data quality and control procedures of all Iqvia products used by the agency, Stifel analyst Shlomo Rosenbaum said it is tough to gauge the potential magnitude and impact of the news. He sees the cost of an audit and the issue of whether the scope of the audit could be significantly expanded as the key questions. While stating that "the optics of the situation are not ideal," Rosenbaum is maintaining a Buy rating and $128 price target on Iqvia shares.

TODAY'S FREE FLY STORIES

BWXT

BWX Technologies

$42.34

-1.849 (-4.18%)

07:58
11/14/18
11/14
07:58
11/14/18
07:58
Initiation
BWX Technologies initiated  »

BWX Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$81.25

-0.97 (-1.18%)

07:58
11/14/18
11/14
07:58
11/14/18
07:58
Initiation
FMC Corporation initiated  »

FMC Corporation initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

LTHM

Livent

$17.80

-0.55 (-3.00%)

07:57
11/14/18
11/14
07:57
11/14/18
07:57
Initiation
Livent initiated  »

Livent initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$28.10

-0.86 (-2.97%)

07:56
11/14/18
11/14
07:56
11/14/18
07:56
Recommendations
eBay analyst commentary  »

eBay tracker shows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GPI

Group 1 Automotive

$56.20

-1.13 (-1.97%)

07:55
11/14/18
11/14
07:55
11/14/18
07:55
Upgrade
Group 1 Automotive rating change  »

Group 1 Automotive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$91.30

2.83 (3.20%)

07:55
11/14/18
11/14
07:55
11/14/18
07:55
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

IQ

iQIYI

$20.33

0.77 (3.94%)

, CBS

CBS

$57.02

-0.125 (-0.22%)

07:55
11/14/18
11/14
07:55
11/14/18
07:55
Hot Stocks
iQIYI licenses CBS Studios' "The Late Late Show with James Corden" in China »

iQIYI (IQ) and CBS (CBS)…

IQ

iQIYI

$20.33

0.77 (3.94%)

CBS

CBS

$57.02

-0.125 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOVN

Novan

$2.50

-0.04 (-1.57%)

07:55
11/14/18
11/14
07:55
11/14/18
07:55
Conference/Events
Novan to host business news update conference call »

Conference call to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

BBT

BB&T

$51.07

0.53 (1.05%)

07:55
11/14/18
11/14
07:55
11/14/18
07:55
Conference/Events
BB&T to hold investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 18

    Oct

ESTA

Establishment Labs

$27.06

2.06 (8.24%)

07:54
11/14/18
11/14
07:54
11/14/18
07:54
Recommendations
Establishment Labs analyst commentary  »

Establishment Labs price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADRNY

Ahold Delhaize

$0.00

(0.00%)

07:53
11/14/18
11/14
07:53
11/14/18
07:53
Downgrade
Ahold Delhaize rating change  »

Ahold Delhaize downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NESRF

Northern Star Resources

07:52
11/14/18
11/14
07:52
11/14/18
07:52
Upgrade
Northern Star Resources rating change  »

Northern Star Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

, GOOGL

Alphabet Class A

$1,048.54

-1.06 (-0.10%)

07:52
11/14/18
11/14
07:52
11/14/18
07:52
Recommendations
Alphabet, Alphabet Class A analyst commentary  »

Barclays removes Alphabet…

GOOG

Alphabet

$1,036.33

-2.89 (-0.28%)

GOOGL

Alphabet Class A

$1,048.54

-1.06 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Mar

MCS

Marcus

$41.02

-0.03 (-0.07%)

07:51
11/14/18
11/14
07:51
11/14/18
07:51
Hot Stocks
Marcus Theatres appoints Greg Creighton as EVP, COO »

Marcus Theatres, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFLY

Shutterfly

$55.01

-1.9 (-3.34%)

07:50
11/14/18
11/14
07:50
11/14/18
07:50
Recommendations
Shutterfly analyst commentary  »

Shutterfly analyst day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEN

Tenneco

$33.61

-0.04 (-0.12%)

, ADNT

Adient

$24.49

2.64 (12.08%)

07:49
11/14/18
11/14
07:49
11/14/18
07:49
Downgrade
Tenneco, Adient, Aptiv, American Axle, BorgWarner, Delphi Technologies, Goodyear Tire, Lear, Magna, Visteon rating change  »

Tenneco downgraded to…

TEN

Tenneco

$33.61

-0.04 (-0.12%)

ADNT

Adient

$24.49

2.64 (12.08%)

APTV

Aptiv

$75.00

0.485 (0.65%)

AXL

American Axle

$11.58

-0.095 (-0.81%)

BWA

BorgWarner

$37.85

-0.04 (-0.11%)

DLPH

Delphi Technologies

$17.20

-0.13 (-0.75%)

GT

Goodyear Tire

$22.54

0.48 (2.18%)

LEA

Lear

$135.70

0.87 (0.65%)

MGA

Magna

$49.47

0.52 (1.06%)

VC

Visteon

$78.68

2.42 (3.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

QRVO

Qorvo

$63.68

-0.12 (-0.19%)

07:49
11/14/18
11/14
07:49
11/14/18
07:49
Recommendations
Qorvo analyst commentary  »

Qorvo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$74.64

-0.47 (-0.63%)

07:46
11/14/18
11/14
07:46
11/14/18
07:46
Recommendations
Jacobs Engineering analyst commentary  »

Jacobs Engineering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

AAP

Advance Auto Parts

$184.66

17.72 (10.61%)

07:46
11/14/18
11/14
07:46
11/14/18
07:46
Recommendations
Advance Auto Parts analyst commentary  »

Advance Auto Parts price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPI

eXp World Holdings

, RMAX

RE/MAX Holdings

$32.03

-0.19 (-0.59%)

07:45
11/14/18
11/14
07:45
11/14/18
07:45
Recommendations
eXp World Holdings, RE/MAX Holdings analyst commentary  »

eXp World Holdings price…

EXPI

eXp World Holdings

RMAX

RE/MAX Holdings

$32.03

-0.19 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SCHW

Charles Schwab

$47.05

0.32 (0.68%)

07:45
11/14/18
11/14
07:45
11/14/18
07:45
Recommendations
Charles Schwab analyst commentary  »

Charles Schwab's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:45
11/14/18
11/14
07:45
11/14/18
07:45
General news
U.S. MBA mortgage market index sank 3.2% »

U.S. MBA mortgage market…

AMRN

Amarin

$15.39

-4.44 (-22.39%)

07:43
11/14/18
11/14
07:43
11/14/18
07:43
Upgrade
Amarin rating change  »

Amarin upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIX

Wix.com

$91.30

2.83 (3.20%)

07:42
11/14/18
11/14
07:42
11/14/18
07:42
Recommendations
Wix.com analyst commentary  »

Wix.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

DHXM

DHX Media

$2.14

0.185 (9.46%)

07:42
11/14/18
11/14
07:42
11/14/18
07:42
Downgrade
DHX Media rating change  »

DHX Media downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.